China: Food and Drug Administration [clinicaltrials_resource:f4f0ea17617afc755400c6bca8ea78a5]
Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes [clinicaltrials:NCT00184561]A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception [clinicaltrials:NCT00185419]Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery [clinicaltrials:NCT00308126]clinicaltrials:NCT00316199Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644) [clinicaltrials:NCT00335075]Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV [clinicaltrials:NCT00348387]Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis [clinicaltrials:NCT00355771]Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms. [clinicaltrials:NCT00356447]A Local Register Study For Major Depression Of Paroxetine Controlled Release [clinicaltrials:NCT00368303]A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients [clinicaltrials:NCT00368706]clinicaltrials:NCT00370071Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes [clinicaltrials:NCT00383877]clinicaltrials:NCT00391274clinicaltrials:NCT00395460clinicaltrials:NCT00395733A Study Of BOTOX For The Treatment Of Glabellar Lines [clinicaltrials:NCT00408785]clinicaltrials:NCT00409006clinicaltrials:NCT00420095Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine [clinicaltrials:NCT00452686]clinicaltrials:NCT00453349Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months [clinicaltrials:NCT00453570]A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation [clinicaltrials:NCT00459719]Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients [clinicaltrials:NCT00461617]Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus [clinicaltrials:NCT00467376]Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients [clinicaltrials:NCT00471965]Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer [clinicaltrials:NCT00477841]A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation [clinicaltrials:NCT00481819]Study Evaluation Tazocin Intervention [clinicaltrials:NCT00488189]Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs [clinicaltrials:NCT00491725]Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart [clinicaltrials:NCT00494988]Efficacy and Safety Study of Two Propofol Formulations [clinicaltrials:NCT00506246]clinicaltrials:NCT00508274Comparison of the Impact of Dialysis Treatment Type on Patient Survival [clinicaltrials:NCT00510549]clinicaltrials:NCT00527605clinicaltrials:NCT00529763clinicaltrials:NCT00536263clinicaltrials:NCT00537771clinicaltrials:NCT00538902A Study of the Treatment of Postmenopausal Women With Osteoporosis [clinicaltrials:NCT00543023]CavatermTM vs TCRE in Women With DUB [clinicaltrials:NCT00549159]
oversight [clinicaltrials_vocabulary:oversight]
China: Food and Drug Administration [clinicaltrials_resource:f4f0ea17617afc755400c6bca8ea78a5]
Bio2RDF identifier
f4f0ea17617afc755400c6bca8ea78a5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f4f0ea17617afc755400c6bca8ea78a5
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:f4f0ea17617afc755400c6bca8ea78a5
title
China: Food and Drug Administration
@en
type
label
China: Food and Drug Administr ...... 0ea17617afc755400c6bca8ea78a5]
@en